DERMALA Inc. logo — Backed by science. Clinically tested. Fighting acne from the...

DERMALA Inc.

Backed by science. Clinically tested. Fighting acne from the inside and outside.

Founded 2014 United States San Diego, United States 9 employees Series A Total: $7.73M Biotechnology, Health Care

General Information

Company Name DERMALA Inc.
Founded Year 2014
Location United States San Diego, United States
Employees 9
Industries Biotechnology, Health Care
Funding Stage Series A
Business Model D2C, Subscription Box, E Commerce
Revenue Model Subscription, Product Sales, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with DERMALA Inc.. To contact DERMALA Inc., visit dermala.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does DERMALA Inc. compare?

A PDF of DERMALA Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting DERMALA Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About DERMALA Inc.

DERMALA Inc., founded in 2014, is a forward-thinking startup at the intersection of Biotechnology and Health Care, with headquarters in the United States. The company is transforming consumer dermatology by utilizing the human microbiome and advanced data analytics to create novel, science-based treatments. Their products aim to combat skin conditions like acne and eczema, enhancing skin health and longevity.

Guided by the slogan, "Backed by science. Clinically tested. Fighting acne from the inside and outside," DERMALA emphasizes its commitment to scientific innovation and clinical validation. The company recently secured a $4.50M Series A investment on 09 November 2020, backed by prominent investors including True Wealth Ventures, Seventure Partners, The Cove Fund, and Johnson & Johnson Robotics and Digital Solutions. This investment underlines its potential to disrupt the dermatology market through revolutionary, data-driven skincare solutions.

Business keywords: Dermatology, Microbiome, Skin Health, Acne Treatment, Eczema Treatment, Clinical Testing, Science-backed, Innovation, Start-up, Consumer Health, Skin Conditions, Data-driven, Longevity, Patented Solutions

Services & Products

Probiotic Acne Supplements
Probiotic Acne Treatment Pads
Personalized Acne Treatment Kits
Microbiome Balancing Skincare
Reusable Skincare Products

Target Customers

Individuals with Acne Health-conscious Consumers Sustainability-focused Customers Young Adults and Teens Women Seeking Comprehensive Skincare Solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $6.73M 4
True Wealth Ventures, Johnson & Johnson Innovation +2
01 Nov 2020
Early VC $1.00M 1
True Wealth Ventures
01 May 2018
Spinout Undisclosed 1
University Ventures
01 Jan 2014

DERMALA Inc. Alternatives & Competitors

View All Alternatives
DERMALA Inc. vs

Life science company focused on skin health. Development of Pro- and Post-biotic ingredients from tr...

Grant
21 employees
Biotechnology, Health Care
DERMALA Inc. vs
Droplette
Droplette United States

Build glowing skin at the cellular level.

Series B
19 employees
Biotechnology, Health Care
DERMALA Inc. vs
Dr. Elsa Jungman
Dr. Elsa Jungman United States

Experience the skin microbiome revolution!

Seed
5 employees
Biotechnology, Consumer Goods

FAQ About DERMALA Inc.

Backed by science. Clinically tested. Fighting acne from the inside and outside.
DERMALA Inc. was founded in 2014.
DERMALA Inc. is headquartered in San Diego, United States.
DERMALA Inc. operates in Biotechnology and Health Care. Its work centres on Dermatology, Microbiome, Skin Health and Acne Treatment. Its customers include Individuals with Acne, Health-conscious Consumers and Sustainability-focused Customers.
DERMALA Inc. has a D2C, Subscription Box and E Commerce business model. Its revenue comes from Subscription, Product Sales and Tiered Pricing.
DERMALA Inc. has approximately 9 employees.
DERMALA Inc. has completed 3 funding rounds, raising a total of $7.73M. The latest funding stage is Series A.
DERMALA Inc. offers: Probiotic Acne Supplements, Probiotic Acne Treatment Pads, Personalized Acne Treatment Kits, Microbiome Balancing Skincare, Reusable Skincare Products.
Top alternatives and competitors to DERMALA Inc. include S-Biomedic NV, Droplette, Dr. Elsa Jungman, Parallel Health, Evvy. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
DERMALA Inc. and S-Biomedic NV are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for DERMALA Inc., https://bouncewatch.com/company/dermala-inc, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes